Projects
International projects:
- National diabetology program – in cooperation with the Institute of Experimental Endocrinology, Slovak Academy of Sciences and University Leipzig. This is an international cooperation held under the label „SUSOD (Sorbs - Uncover the Secrets Of Disease)“ Project name: „Prevalence of diabetes mellitus in Slovak Republic – genetic screening of the population“ Duration of the study: 2007 – still in progress. (Principal coordinator in Slovakia: Prof. M. Mokáň, MD, D.Sc., FRCP Edin, co-investigator: Prof. P. Galajda, MD, PhD)
- Bilateral cooperation with Department of Diabetes, Royal Infirmary of Edinburgh, Scotland: Hypoglycaemia and driving in people with insulin treated diabetes. Duration of the project: 2007 – still in progress. (Investigators: Prof. Brian M. Frier, Prof. M. Mokáň, MD, D.Sc., FRCP Edin)
APVV Grants
• APVV-MVP-24-0252 "Modification of Gut Microbiome in Patients with Primary IgA Nephropathy." Principal Investigator: MUDr. Karol Graňák, PhD.
• APVV-17-0054 “New oral anticoagulants in the prevention of major cardiovascular diseases – their effects on platelets, drug interactions, safety, and use in oncology patients.” (2018 – 2022) Principal investigator: MUDr. Michal Mokáň, PhD
• APVV-14-0153 “Adipocytokine regulation in young patients with acute coronary syndrome.” (2015 – 2019) Principal investigator: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin
• APVV-0222-11 “Prediction of restenosis and stent thrombosis in patients with acute coronary syndrome following percutaneous coronary intervention.” (2012 – 2015) Principal investigator: Prof. MUDr. Peter Kubisz, DrSc., Co-investigators (1st Department of Internal Medicine): Prof. MUDr. M. Mokáň, DrSc., FRCP Edin; Prof. MUDr. P. Galajda, CSc.; MUDr. M. Samoš
VEGA research grants
• VEGA 1/0168/25 “Effect of GLP1-RA treatment in patients with chronic heart failure with preserved left ventricular ejection fraction: monitoring clinical, novel molecular and imaging markers.” (2025–2027) Principal investigator: Assoc. Prof. MUDr. Tomáš Bolek, PhD
• VEGA 1/0238/21 “Continuous glucose monitoring and glycemic variability in the early post-transplant period as a predictor of complications after kidney transplantation.” (2021–2023), Principal investigators: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin / Prof. MUDr. Ivana Dedinská, PhD
• VEGA 1/0090/20 “New trends in therapy and novel markers of progression in chronic heart failure with preserved left ventricular systolic function in patients with type 2 diabetes mellitus.” (2020–2022), Principal investigator: Assoc. Prof. MUDr. Matej Samoš, PhD
• VEGA 1/0023/19 “Adipocytokines as novel markers of acute rejection in kidney transplantation.” (2019–2021), Principal investigator: Prof. MUDr. Ivana Dedinská, PhD
• VEGA 1/0160/16 “Diagnostic and prognostic value of parameters of adipocytokine regulation and glucose homeostasis in cachectic patients.” (2016–2018), Principal investigator: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin
• VEGA 1/0228/13 “Identification of markers of the obesity paradox in patients with ischemic heart disease and chronic heart failure.”(2013–2015), Principal investigator: Prof. MUDr. Marián Mokáň, DrSc., FRCP Edin
• VEGA 1/0053/11 “Metabolic and immunological aspects of cardiac cachexia, category B.” (2011–2013), Principal investigator: Prof. MUDr. P. Galajda, CSc.
• VEGA 1/0005/08 “Metabolic syndrome, adipose tissue hormones and the risk of vascular complications.” (2008–2011), Principal investigator: Prof. MUDr. P. Galajda, CSc.
• VEGA 1/4284/07 “Association of HLA class II alleles with type 1A diabetes mellitus in the Slovak population.” Investigators: Prof. MUDr. M. Mokáň, DrSc., FRCP Edin; Assoc. Prof. MUDr. J. Sadloňová, CSc.; Prof. MUDr. P. Galajda, CSc.; MUDr. D. Kantárová, PhD; RNDr. Stuchliková; MUDr. M. Kutlák; MUDr. M. Migra
• VEGA 1/1189/04 “Metabolic syndrome, subclinical inflammatory response and cardiovascular disease risk.” Co-funded by the Slovak Diabetology Society (2004–2007), Principal investigator: Prof. MUDr. P. Galajda, CSc.
• VEGA 1/8149/01 “Heterogeneity of the metabolic syndrome and disorders of hemostasis.” (2001–2003), Principal investigator: Assoc. Prof. MUDr. P. Galajda, CSc.
• VEGA 1/8155/01 “The role of nitric oxide in airway hyperreactivity.” (2001–2003), Co-investigator for the 1st Department of Internal Medicine: Assoc. Prof. MUDr. Sadloňová, CSc.
Grants of Professional Societies
• Grant of the Slovak Cardiology Society – Use of thromboelastometry in monitoring the effectiveness of antiplatelet therapy in patients with acute STEMI (2013), Principal investigator: MUDr. M. Samoš
• National Diabetology Project – Prevalence of Diabetes Mellitus in Slovakia (2003–2007), National Coordinator: Prof. MUDr. M. Mokáň, DrSc., FRCP Edin, Co-investigators: Prof. MUDr. P. Galajda, CSc.; MUDr. D. Prídavková, PhD; MUDr. Ľ. Šutarík, CSc.
Comenius University Grants (GUK)
• Excellent GUK/3034/2025 „Micro-RNA and post-transplant diabetes mellitus“ Principal Investigator: MUDr. A. Kollár
• GUK/1210/2025 - Epicardial Fat and Cardiovascular Risk in Patients with Metabolic Syndrome. Principal Investigator: MUDr. P. Lecký
• GUK/1229/2025 - Effect of GLP-1 Receptor Agonist Therapy in Patients with Heart Failure with Preserved Ejection Fraction: Evaluation of Clinical, Novel Laboratory, and Echocardiographic Parameters. Principal Investigator: MUDr. Z. Miertová
• Excellent GUK/3030/2024 – Post-translationally modified urinary fetuin-A as a marker of renal graft failure prediction. Principal investigator: MUDr. P. Kleinová
• Excellent GUK/3248/2024 – Changes in platelet aggregation in the diagnosis of acute graft rejection. Principal investigator: MUDr. T. Blichová
• GUK/143/2023 – New molecular markers in the development and progression of heart failure in obese individuals. Principal investigator: MUDr. Z. Moravčíková
• GUK/32/2023 – Impact of SCFA on changes in gut microbiota and incidence of complications in post-kidney transplantation patients. Principal investigator: MUDr. P. Kleinová
• GUK/318/2022 – Hemostasis disorders in autoimmune diseases. Principal investigator: MUDr. M. J. Péč
• GUK/240/2022 – The role of adipocytokines in the development of glomerulonephritis. Principal investigator: MUDr. M. Beliančinová
• GUK/183/2021 – Hemostasis disorders in autoimmune diseases. Principal investigator: MUDr. M. J. Péč
• GUK/302/2020 – Use of laboratory monitoring of anti-Xa activity in patients with atrial fibrillation and bleeding during treatment with xabans. Principal investigator: MUDr. K. Grilusová
• GUK/187/2020 – MicroRNA-126 as a risk marker for type 2 diabetes mellitus. Principal investigator: MUDr. J. Benko
• GUK/401/2018 – Risk of hypoglycemia in patients with diabetes mellitus treated with insulin pump therapy. Principal investigator: MUDr. V. Sváková
• GUK/386/2018 – Use of thromboelastometry in monitoring therapy with novel oral anticoagulants. Principal investigator: MUDr. B. Korpallová
• GUK/359/2018 – New risk markers for the development of type 2 diabetes mellitus. Principal investigator: MUDr. J. Benko
• GUK/18/2016 – Effect of new oral anticoagulants on platelet aggregation in patients with thromboembolic disease. Principal investigator: MUDr. M. Vnučák
• GUK/93/2016 – Metabolic syndrome and aspirin resistance. Principal investigator: MUDr. R. Michalová
• GUK/60/2014 – The role of adiponectin in the development of pulmonary embolism in patients with metabolic syndrome. Principal investigator: MUDr. S. Daruľová
• GUK/122/2013 – The role of adiponectin in the development of pulmonary embolism in patients with metabolic syndrome. Principal investigator: MUDr. S. Daruľová
• GUK/54/2012 – Use of thromboelastometry in monitoring the effectiveness of antiplatelet therapy in patients with acute STEMI. Principal investigator: MUDr. M. Samoš
• GUK/178/2012 – Acute thromboembolic disease – risk stratification and etiology in patients with metabolic syndrome. The role of thrombolytic therapy in modern treatment of pulmonary embolism. Principal investigator: MUDr. S. Daruľová
• GUK/289/2011 – Prognostic significance of serum adiponectin and leptin levels in relation to severity of coronary artery disease and heart failure in patients with the obesity paradox. Principal investigator: MUDr. M. Stančík
• GUK/47/2009 – Insulin gene polymorphism in patients with type 1 diabetes mellitus. Principal investigators: MUDr. D. Kantárová, PhD; MUDr. M. Kutlák
European Social Fund (ESF) Projects
• ESF – ITMS code: 313011V344 “Long-term strategic research in the prevention, intervention, and mechanisms of obesity and its comorbidities.” Duration: 01.09.2019 – 28.02.2023 Responsible investigators (JLF UK): Prof. RNDr. Erika Halašová, PhD; Prof. MUDr. Peter Galajda, CSc.
• ESF – ITMS code: 26120230033 “Residency program for general practitioners at the Jessenius Faculty of Medicine, Comenius University in Martin.” Principal investigator: Prof. MUDr. Peter Galajda, CSc.
• ESF – ITMS code: 26220220111 “Centre of Excellence for Research in Personalized Therapy (CEVYPET).” Co-investigator (1st Department of Internal Medicine): Prof. MUDr. M. Mokáň, DrSc., FRCP Edin
• ESF – “System for comprehensive evaluation of the quality of the educational process and scientific-research activities at JLF UK in Martin.” Coordinator: Prof. MUDr. Peter Galajda, CSc.
• ESF – “Support of human resource development using the most modern methods and forms of education at JLF UK in Martin.” Co-investigator: Prof. MUDr. Peter Galajda, CSc.
• ESF – ITMS code: 26220220111 “Carcinogenic and toxic metals in the environment and workplace.” (2010–2013, Co-investigator: Assoc. Prof. MUDr. J. Sadloňová, CSc.
• ESF – “Virtual and simulation-based education as a new form of teaching at JLF UK in Martin.” Investigators: Prof. MUDr. Peter Galajda, CSc.; Assoc. Prof. MUDr. J. Sadloňová, CSc.
• ESF – “Support for innovative forms of education for students studying in the English language.” Co-investigator: Assoc. Prof. MUDr. J. Sadloňová, CSc.